Pulmonary arterial hypertension (PAH ... When a condition's cause is unknown, it's called idiopathic. Idiopathic PAH is the most common type of PAH. While the exact cause of idiopathic PAH ...

Heart–lung transplantation and bilateral lung transplant provide a good long-term survival benefit for patients with advanced PAH (Figure 5). A recent single-center, retrospective series from ...

Renal dysfunction is a recognized complication of transplant related immunosuppression, in particular cyclosporin and tacrolimus, with some contribution from perioperative hemodynamic shifts ...

The 6th World Symposium on Pulmonary Hypertension Task Force on hemodynamic ... The Registry to Evaluate Early and Long-Term Pulmonary Arterial Disease Management (REVEAL) was initiated in the ...

In pulmonary hypertension, a combination of metabolic and mechanical dysfunction leads to irreversible vascular damage.

Pulmonary arterial hypertension (PAH) is a rare and severe lung disease with a life-threatening prognosis. After several positive trials, a recent study has confirmed the efficacy of a biotherapy ...

Sotatercept improves exercise capacity and delays the time to clinical worsening in patients with World Health Organization (WHO) functional class II or III pulmonary arterial hypertension.